Resources
Filter by Topic
- Infographic
For a more comprehensive view of the patient journey and experience, life sciences organizations must turn data into insights. Panalgo’s Instant Health Data (IHD) platform...
- Case Study
In this case study, we dive into how this company educated employees in data science analytics techniques across departments with various skillsets and fostered a...
- Blogs
Today’s life sciences companies need efficient ways to turn real-world data into meaningful insights. To explore how Panalgo’s Instant Health Data (IHD) and IHD Cloud...
- Case Study
With Panalgo’s IHD, a company successfully accelerated its ability to derive actionable insights from real-world data, leading to tangible business benefits.
- Press Releases
Global provider of pharma intelligence solutions joins the ranks of Waymo, Nvidia, Duolingo, and more
- Case Study
A biopharma manufacturer developing a rare disease treatment needed to quantify its potential patient population.
- Case Study
When a medical device company was preparing to launch a new product, it turned to Panalgo to generate robust data for an HEOR study on...
Gaining Rapid Understanding of COVID-19 Through a Real-world Data Lens
In this Healthcare IT Today article, Joseph Menzin, PhD, dives into the COVID-19 pandemic and the need for more timely data in the course of
The Future of Healthcare: “We need to recognize that health outcomes are not just about medical care”, With Dr. Joseph Menzin of Boston Health Economics
Panalgo CEO, Joseph Menzin, PhD, gets interviewed as a leader in the healthcare industry. Joe talks the founding of BHE and his 30 years of
Life science companies combine to form COVID-19 research database
Click here to read the article.
Leading Healthcare Companies Announce COVID-19 Research Database
A consortium of leading healthcare companies today announced the launch of the COVID-19 Research Database, a secure repository of HIPAA-compliant, de-identified and limited patient-level data
ICER’s Development and Use of RWE: 5 Areas for Concern
The pervasiveness of real-world data (RWD) and the need to understand outcomes in clinical practice have galvanized the ubiquity and utility of real-world evidence (RWE).
Estimated Lifetime Economic Burden of Type 1 Diabetes
Authors: Matthew Sussman, Jennifer Benner, Dr. Michael Haller, Dr. Marian Rewers, Dr. Robert Griffiths Published: Diabetes Technology & Therapeutics Click here to view the article.
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization